Literature DB >> 25207187

Efficiency and cost analysis of cell saver auto transfusion system in total knee arthroplasty.

Mustafa Gökhan Bilgili1, Ersin Erçin1, Gökhan Peker2, Cemal Kural1, Serdar Hakan Başaran3, Altuğ Duramaz1, Cevdet Avkan1.   

Abstract

BACKGROUND: Blood loss and replacement is still a controversial issue in major orthopaedic surgery. Allogenic blood transfusion may cause legal problems and concerns regarding the transmission of transfusion-related diseases. Cellsaver Systems (CSS) were developed as an alternative to allogenic transfusion but CSS transfusion may cause coagulation, infection and haemodynamic instability. AIMS: Our aim was to analyse the efficiency and cost analysis of a cell saver auto-transfusion system in the total knee arthroplasty procedure. STUDY
DESIGN: Retrospective comparative study.
METHODS: Those patients who were operated on by unilateral, cemented total knee arthroplasty (TKA) were retrospectively evaluated. Group 1 included 37 patients who were treated using the cell saver system, and Group 2 involved 39 patients who were treated by allogenic blood transfusion. The groups were compared in terms of preoperative haemoglobin and haematocrit levels, blood loss and transfusion amount, whether allogenic transfusion was made, degree of deformity, body mass index and cost.
RESULTS: No significant results could be obtained in the statistical comparisons made in terms of the demographic properties, deformity properties, preoperative laboratory values, transfusion amount and length of hospital stay of the groups. Average blood loss was calculated to be less in Group 1 (p<0.05) and cost was higher in Group 1 (p<0.05).
CONCLUSION: Cell saver systems do not decrease the amount of allogenic blood transfusion and costs more. Therefore, the routine usage of the auto-transfusion systems is a controversial issue. Cell saver system usage does not affect allogenic blood transfusion incidence or allogenic blood transfusion volume. It was found that preoperative haemoglobin and body mass index rates may affect allogenic blood transfusion. Therefore, it is foreseen that auto-transfusion systems could be useful in patients with low haemoglobin level and body mass index.

Entities:  

Keywords:  Cell saver system; cost; total knee arthroplasty

Year:  2014        PMID: 25207187      PMCID: PMC4115923          DOI: 10.5152/balkanmedj.2014.13267

Source DB:  PubMed          Journal:  Balkan Med J        ISSN: 2146-3123            Impact factor:   2.021


  22 in total

1.  Shed blood re-transfusion provides no benefit in computer-assisted primary total knee arthroplasty.

Authors:  Dae-Hee Lee; Debabrata Padhy; Soon-Hyuck Lee; Tae-Kwon Kim; Jungsoon Choi; Seung-Beom Han
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2010-09-03       Impact factor: 4.342

2.  Clinical efficacy of postoperative autologous transfusion of filtered shed blood in hip and knee arthroplasty.

Authors:  D Strümper; E W G Weber; S Gielen-Wijffels; R Van Drumpt; S Bulstra; R Slappendel; M E Durieux; M A E Marcus
Journal:  Transfusion       Date:  2004-11       Impact factor: 3.157

3.  Coagulopathy after reinfusion of autologous scavenged red blood cells.

Authors:  D J Murray; K Gress; S L Weinstein
Journal:  Anesth Analg       Date:  1992-07       Impact factor: 5.108

4.  Transfusion of autologous blood from reinfusion systems in total knee arthroplasty.

Authors:  A Martin; A von Strempel
Journal:  Int Orthop       Date:  2006-05-31       Impact factor: 3.075

Review 5.  Peri-operative blood management in elective orthopaedic surgery. A critical review of the literature.

Authors:  A F C M Moonen; T D Neal; P Pilot
Journal:  Injury       Date:  2006-12       Impact factor: 2.586

6.  Postoperative re-perfusion of drained blood in patients undergoing total knee arthroplasty: is it effective and cost-efficient?

Authors:  John M Kirkos; Christos Th Krystallis; Panayotis A Konstantinidis; Kyriakos A Papavasiliou; Margaritis J Kyrkos; Lazaros G Ikonomidis
Journal:  Acta Orthop Belg       Date:  2006-01       Impact factor: 0.500

7.  A prospective audit of blood usage post primary total knee arthroplasty.

Authors:  Aaron Glynn; Thomas McCarthy; Maire McCarroll; Paraic Murray
Journal:  Acta Orthop Belg       Date:  2006-01       Impact factor: 0.500

8.  Autotransfusion drains in total knee replacement. Are they alternatives to homologous transfusion?

Authors:  T Abuzakuk; V Senthil Kumar; Y Shenava; C Bulstrode; J A Skinner; S R Cannon; T W Briggs
Journal:  Int Orthop       Date:  2006-06-08       Impact factor: 3.075

9.  An economic justification for autologous blood re-infusion in primary total knee replacement surgery.

Authors:  J E Rees; R Jeavons; J H Dixon
Journal:  Ann R Coll Surg Engl       Date:  2005-03       Impact factor: 1.891

10.  Blood loss management in high-risk patients undergoing total knee arthroplasty: a comparison of two techniques.

Authors:  Fred D Cushner; Gwo-Chin Lee; Giles R Scuderi; Steven J Arsht; W Norman Scott
Journal:  J Knee Surg       Date:  2006-10       Impact factor: 2.757

View more
  10 in total

1.  A decision model and cost analysis of intra-operative cell salvage during hepatic resection.

Authors:  Madeline Lemke; Gareth Eeson; Yulia Lin; Jordan Tarshis; Julie Hallet; Natalie Coburn; Calvin Law; Paul J Karanicolas
Journal:  HPB (Oxford)       Date:  2016-03-09       Impact factor: 3.647

2.  The role of intraoperative cell salvage system on blood management in major orthopedic surgeries: a cost-benefit analysis.

Authors:  Altuğ Duramaz; Mustafa Gökhan Bilgili; Berhan Bayram; Nezih Ziroğlu; Erdem Edipoğlu; Halil Nadir Öneş; Cemal Kural; Mustafa Cevdet Avkan
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-12-06

Review 3.  Efficiency and Safety of Intravenous Tranexamic Acid in Simultaneous Bilateral Total Knee Arthroplasty: A Systematic Review and Meta-analysis.

Authors:  Xuan Jiang; Xin-Long Ma; Jian-Xiong Ma
Journal:  Orthop Surg       Date:  2016-08       Impact factor: 2.071

4.  The efficacy of a thrombin-based hemostatic agent in primary total knee arthroplasty: a meta-analysis.

Authors:  Chen Wang; Zhe Han; Tao Zhang; Jian-xiong Ma; Xuan Jiang; Ying Wang; Xin-long Ma
Journal:  J Orthop Surg Res       Date:  2014-10-15       Impact factor: 2.359

5.  Combined use of intravenous and topical versus intravenous tranexamic acid in primary total knee and hip arthroplasty: a meta-analysis of randomised controlled trials.

Authors:  Jun-Feng Li; Hang Li; Hui Zhao; Jun Wang; Shen Liu; Yang Song; Hong-Fen Wu
Journal:  J Orthop Surg Res       Date:  2017-02-02       Impact factor: 2.359

Review 6.  Is combined topical and intravenous tranexamic acid superior to single use of tranexamic acid in total joint arthroplasty?: A meta-analysis from randomized controlled trials.

Authors:  Liqing Yang; Shuai Du; Yuefeng Sun
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

Review 7.  The efficacy and safety of intravenous tranexamic acid in hip fracture surgery: A systematic review and meta-analysis.

Authors:  Yi-Ming Qi; Hai-Peng Wang; Ying-Juan Li; Bin-Bin Ma; Tian Xie; Chen Wang; Hui Chen; Yun-Feng Rui
Journal:  J Orthop Translat       Date:  2019-04-19       Impact factor: 5.191

8.  Complications of Tranexamic Acid in Orthopedic Lower Limb Surgery: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Davide Reale; Luca Andriolo; Safa Gursoy; Murat Bozkurt; Giuseppe Filardo; Stefano Zaffagnini
Journal:  Biomed Res Int       Date:  2021-01-16       Impact factor: 3.411

9.  Comparison of oral and intravenous tranexamic acid in total hip arthroplasty: a systematic review and meta-analysis.

Authors:  Yiming Qi; Yingjuan Li; Chen Wang; Hui Chen; Yunfeng Rui
Journal:  Arthroplasty       Date:  2020-04-08

Review 10.  Is the combined application of both drain-clamping and tranexamic acid superior to the single use of either application in patients with total-knee arthroplasty?: A meta-analysis of randomized controlled trials.

Authors:  Yan-Hong Han; He-Tao Huang; Jian-Ke Pan; Ling-Feng Zeng; Gui-Hong Liang; Hao-Dong Liang; Wei-Yi Yang; Da Guo; Jun Liu
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.